1. Home
  2. CNS vs PLSE Comparison

CNS vs PLSE Comparison

Compare CNS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

HOLD

Current Price

$78.18

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$48.79

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNS
PLSE
Founded
1986
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
CNS
PLSE
Price
$78.18
$48.79
Analyst Decision
Hold
Buy
Analyst Count
2
1
Target Price
$71.50
$22.00
AVG Volume (30 Days)
177.9K
476.8K
Earning Date
04-16-2026
05-07-2026
Dividend Yield
3.96%
N/A
EPS Growth
N/A
N/A
EPS
1.77
N/A
Revenue
$427,536,000.00
N/A
Revenue This Year
$4.71
$840.00
Revenue Next Year
$4.37
$287.54
P/E Ratio
$45.15
N/A
Revenue Growth
4.07
N/A
52 Week Low
$58.39
$12.56
52 Week High
$86.56
$55.37

Technical Indicators

Market Signals
Indicator
CNS
PLSE
Relative Strength Index (RSI) 40.64 58.94
Support Level $76.15 $24.27
Resistance Level $79.59 N/A
Average True Range (ATR) 2.51 2.96
MACD -0.62 -0.28
Stochastic Oscillator 16.47 34.14

Price Performance

Historical Comparison
CNS
PLSE

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $102.5 billion in managed assets at the end of July 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Share on Social Networks: